548 related articles for article (PubMed ID: 11282421)
1. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition.
Cross MJ; Claesson-Welsh L
Trends Pharmacol Sci; 2001 Apr; 22(4):201-7. PubMed ID: 11282421
[TBL] [Abstract][Full Text] [Related]
2. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis.
Gerwins P; Sköldenberg E; Claesson-Welsh L
Crit Rev Oncol Hematol; 2000 Jun; 34(3):185-94. PubMed ID: 10838264
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.
Sledge GW
Semin Oncol; 2002 Jun; 29(3 Suppl 11):104-10. PubMed ID: 12138404
[TBL] [Abstract][Full Text] [Related]
4. VEGF: an update on biological and therapeutic aspects.
Ferrara N
Curr Opin Biotechnol; 2000 Dec; 11(6):617-24. PubMed ID: 11102799
[TBL] [Abstract][Full Text] [Related]
5. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis for ischemic cardiovascular disease.
Freedman SB; Isner JM
J Mol Cell Cardiol; 2001 Mar; 33(3):379-93. PubMed ID: 11181008
[TBL] [Abstract][Full Text] [Related]
7. VEGF receptor signal transduction.
Matsumoto T; Claesson-Welsh L
Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
[TBL] [Abstract][Full Text] [Related]
8. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
9. The biology of VEGF and its receptors.
Ferrara N; Gerber HP; LeCouter J
Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
Zachary I
IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
12. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
Eriksson K; Magnusson P; Dixelius J; Claesson-Welsh L; Cross MJ
FEBS Lett; 2003 Feb; 536(1-3):19-24. PubMed ID: 12586331
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factors and angiogenesis in eye disease.
Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
[TBL] [Abstract][Full Text] [Related]
14. VEGF receptor signaling in tumor angiogenesis.
McMahon G
Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats.
Iruela-Arispe ML; Lombardo M; Krutzsch HC; Lawler J; Roberts DD
Circulation; 1999 Sep; 100(13):1423-31. PubMed ID: 10500044
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease.
Henning RJ
Future Cardiol; 2016 Sep; 12(5):585-99. PubMed ID: 27420190
[TBL] [Abstract][Full Text] [Related]
19. Advances in the use of angiogenesis inhibitors in cancer.
Pinedo HM
Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
[No Abstract] [Full Text] [Related]
20. Clinical applications of angiogenic growth factors and their inhibitors.
Ferrara N; Alitalo K
Nat Med; 1999 Dec; 5(12):1359-64. PubMed ID: 10581076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
